Bioxytran Inc (BIXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Operating Expenses | 1,689 | 776 | 114 | 112 | 266 |
| Operating Income | -1,689 | -776 | -114 | -112 | -266 |
| Interest Expense | 87 | 80 | 87 | 740 | 108 |
| Other Income | 0 | -15 | -1 | -76 | -167 |
| Pre-tax Income | -1,776 | -871 | -202 | -929 | -541 |
| Net Income Continuous | -1,776 | -871 | -202 | -929 | -541 |
| Minority Interests | -155 | N/A | 0 | 0 | 0 |
| Net Income | $-1,622 | $-810 | $-202 | $-929 | $-541 |
| EPS Basic Total Ops | -0.02 | -0.01 | 0.00 | -0.01 | -0.01 |
| EPS Basic Continuous Ops | -0.02 | -0.01 | 0.00 | -0.01 | -0.01 |
| EPS Diluted Total Ops | -0.02 | -0.01 | 0.00 | -0.01 | -0.01 |
| EPS Diluted Continuous Ops | -0.02 | -0.01 | 0.00 | -0.01 | -0.01 |
| EBITDA(a) | $-1,689 | $-776 | $-98 | $-36 | $-99 |